Potential approaches for heterologous prion protein treatment of prion diseases.

about

Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.Recombinant PrP and Its Contribution to Research on Transmissible Spongiform Encephalopathies.

P2860

Q44607866-35DB1490-61A2-4905-9A79-58A3F5B5A2FF Q47294251-91520F49-3B1F-484C-8E58-588C6C33AF95

P2860

Potential approaches for heterologous prion protein treatment of prion diseases.

Item

http://www.wikidata.org/entity/Q40883026

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Potential approaches for heterologous prion protein treatment of prion diseases.

@en

type

Item

label

Potential approaches for heterologous prion protein treatment of prion diseases.

@en

prefLabel

Potential approaches for heterologous prion protein treatment of prion diseases.

@en

P1476

Potential approaches for heterologous prion protein treatment of prion diseases.

@en

P2093

Davis M Seelig

http://www.w3.org/2001/XMLSchema#string

Patricia A Goodman

http://www.w3.org/2001/XMLSchema#string

P2860

Effective gene therapy in a mouse model of prion diseases

Treatment of Prion Disease with Heterologous Prion Proteins

Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease.

Live cell fluorescence resonance energy transfer predicts an altered molecular association of heterologous PrPSc with PrPC.

Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence.

Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom.

Transmissible spongiform encephalopathies and prion protein interconversions.

Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform

Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers

Rabbits are not resistant to prion infection

P304

18-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/19336896.2015.1123372

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pamela J. Skinner

P577

2015-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26636482

http://www.w3.org/2001/XMLSchema#string

P921

Prion protein family

P932

4981202

http://www.w3.org/2001/XMLSchema#string

Potential approaches for heterologous prion protein treatment of prion diseases.

about

P2860

P2860

Potential approaches for heterologous prion protein treatment of prion diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932